Evaluation of Thyroid Dysfunction in Children: Screening Approaches and Referral Triggers to Endocrinology

Emine Gozde Ozdrama Yildiz1, Eren Vurgun2, Digdem Bezen3

  • 1Department of Pediatrics, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Türkiye.

Clinical Pediatrics
|June 4, 2026
PubMed

Insights

Pediatric thyroid dysfunction screening is crucial. Thyroid-stimulating hormone (TSH) alone is adequate for initial screening in children, but follow-up testing is recommended for abnormal results.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Chemistry
  • Diagnostic Screening

Background:

  • Thyroid diseases are prevalent pediatric endocrinological disorders.
  • Abnormal thyroid function tests (TFTs) in children often lead to referrals to specialists.
  • Accurate diagnosis is essential for appropriate management and to avoid unnecessary specialist consultations.

Purpose of the Study:

  • To determine the actual prevalence of thyroid dysfunction in children referred for abnormal TFTs.
  • To evaluate the diagnostic utility of thyroid-stimulating hormone (TSH) and free thyroxine (fT4) in this pediatric population.
  • To establish optimal screening and referral guidelines for pediatric thyroid disorders.

Main Methods:

  • Retrospective analysis of 204 children referred to pediatric endocrinology.
  • Evaluation of clinical characteristics and TFT results (TSH, fT4) at initial and follow-up visits.
  • Comparison of initial screening results with final diagnoses of thyroid dysfunction.

Main Results:

  • Nearly half (49.5%) of referred children did not have thyroid dysfunction after specialist evaluation.
  • Thyroid-stimulating hormone (TSH) alone was sufficient for initial screening.
  • Among children with initially low TSH, 80% lacked thyroid dysfunction; 57.6% with high TSH had dysfunction.
  • Persistently high TSH at follow-up increased the risk of thyroid dysfunction 19.4-fold.

Conclusions:

  • Thyroid-stimulating hormone (TSH) is a reliable sole screening marker for pediatric thyroid dysfunction.
  • Initial abnormal TSH levels warrant repeat TSH and free thyroxine (fT4) testing after 4-12 weeks before pediatric endocrinology referral.
  • This approach can reduce unnecessary referrals and optimize resource utilization in pediatric endocrinology.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...